These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


571 related items for PubMed ID: 15122332

  • 1. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
    Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS.
    Oncogene; 2004 Jun 10; 23(27):4681-9. PubMed ID: 15122332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
    Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, Nirmala C, Lakka SS, Adachi Y, Kyritsis AP, Ali-Osman F, Sawaya R, Fuller GN, Rao JS.
    Cancer Res; 2000 Dec 15; 60(24):6851-5. PubMed ID: 11156378
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
    Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Oncogene; 2002 Aug 15; 21(36):5601-8. PubMed ID: 12165859
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.
    Jadhav U, Chigurupati S, Lakka SS, Mohanam S.
    Int J Oncol; 2004 Nov 15; 25(5):1407-14. PubMed ID: 15492832
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao VH, Sioka C, Rao JS.
    J Biol Chem; 2005 Jun 10; 280(23):21882-92. PubMed ID: 15824107
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
    Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, Adachi Y, Siddique K, Gujrati M, Olivero W, Dinh DH, Kouraklis G, Kyritsis AP, Rao JS.
    Oncogene; 2002 Nov 14; 21(52):8011-9. PubMed ID: 12439751
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
    Sun Y, Liu M, Yang B, Lu J, Li B.
    Cancer Invest; 2008 Dec 14; 26(10):984-9. PubMed ID: 19093256
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.
    Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang W.
    Cancer Res; 2003 Aug 01; 63(15):4315-21. PubMed ID: 12907597
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.